Top Markets
Coin of the day
Cadrenal Therapeutics, Inc. Common Stock Cadrenal Therapeutics, Inc. Common Stock

Cadrenal Therapeutics, Inc. Common Stock

CVKD
주식 순위 #33958
Cadrenal Therapeutics, Inc. operates as a biopharmaceutical enterprise... Cadrenal Therapeutics, Inc. operates as a biopharmaceutical enterprise primarily engaged in clinical development. The company's core focus is the advancement of Tecarfarin, a novel therapeutic agent that has received orphan drug designation. This treatment is engineered to prevent systemic thromboembolism originating from cardiac issues in patients suffering from both end-stage renal disease and atrial fibrillation. Established in 2022, the firm is headquartered in Ponte Vedra, Florida.
주가
$1.83
마지막 동기화: 2026-08-14
시가총액
$6.53M
변동 (1일)
-1.61%
변동 (1년)
-85.57%
국가
US
거래 Cadrenal Therapeutics, Inc. Common Stock (CVKD)

카테고리

Cadrenal Therapeutics, Inc. Common Stock (CVKD)의 주가 이력
최고 종가: $1.89 (2026-08-01 기준)

최저 종가: $46.78 (2023-01-01 기준)
Cadrenal Therapeutics, Inc. Common Stock의 주가 이력 (2023 ~ 2026)
연간 주가 성과
연도 성과
2026 (TTM) -11.31%
2025 -35.19%
2024 69.00%
2023 0.00%
유사 기업 또는 경쟁사의 주가
회사 주가 변동률 1년% 국가
$505.24 28.63%
US
$846.09 29.41%
NL
$731.69 6.47%
CH
$1.07K -6.40%
KR
$251.82 11.75%
BE